Clinical practice guidelines for the diagnosis and treatment of scabies

Basit Öğe Kaydı
dc.authoridTaylan Ozkan, Aysegul/0000-0001-8421-3625
dc.authoridDEMIR, Gulay/0000-0002-3916-7639
dc.authoridDurdu, Murat/0000-0003-1247-3932
dc.authoridAktas, Habibullah/0000-0001-9239-1659
dc.contributor.authorUzun, Soner
dc.contributor.authorDurdu, Murat
dc.contributor.authorYurekli, Aslan
dc.contributor.authorMulayim, Mehmet K.
dc.contributor.authorAkyol, Melih
dc.contributor.authorVelipasaoglu, Sevtap
dc.contributor.authorHarman, Mehmet
dc.date.accessioned2025-03-20T09:50:47Z
dc.date.available2025-03-20T09:50:47Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractScabies, caused by the Sarcoptes scabiei var hominis mite burrowing into the skin, is a highly contagious disease characterized by intense nocturnal itching. Its global impact is considerable, affecting more than 200 million individuals annually and posing significant challenges to healthcare systems worldwide. Transmission occurs primarily through direct skin-to-skin contact, contributing to its widespread prevalence and emergence as a substantial public health concern affecting large populations. This review presents consensus-based clinical practice guidelines for diagnosing and managing scabies, developed through the fuzzy Delphi method by dermatology, parasitology, pediatrics, pharmacology, and public health experts. The presence of burrows containing adult female mites, their eggs, and excreta is the diagnostic hallmark of scabies. Definitive diagnosis typically involves direct microscopic examination of skin scrapings obtained from these burrows, although dermoscopy has become a diagnostic tool in clinical practice. Treatment modalities encompass topical agents, such as permethrin, balsam of Peru, precipitated sulfur, and benzyl benzoate. In cases where topical therapy proves inadequate or in instances of crusted scabies, oral ivermectin is recommended as a systemic treatment option. This comprehensive approach addresses the diagnostic and therapeutic challenges associated with scabies, optimizing patient care, and management outcomes.
dc.identifier.doi10.1111/ijd.17327
dc.identifier.endpage1656
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue12
dc.identifier.pmid38922701
dc.identifier.scopus2-s2.0-85196636612
dc.identifier.scopusqualityQ1
dc.identifier.startpage1642
dc.identifier.urihttps://doi.org/10.1111/ijd.17327
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2319
dc.identifier.volume63
dc.identifier.wosWOS:001252213100001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofInternational Journal of Dermatology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250319
dc.subjectscabies
dc.subjectneglected tropical diseases
dc.subjectdiagnostics
dc.subjecttreatment
dc.subjectinfestations
dc.subjectelimination
dc.subjectprevention
dc.titleClinical practice guidelines for the diagnosis and treatment of scabies
dc.typeReview

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu